La Jolla Pharmaceutical Company Gains 81.12%
Mon, Jul 11, 2022 at 08:33 PM
La Jolla Pharmaceutical Company (LJPC:NASDAQ) jumped higher at $6.14, representing a gain of 81.1%. On Mon, Jul 11, 2022, LJPC:NASDAQ touched a New 2-Week High of $6.14. The stock got featured on our News Catalysts scanner on Mon, Jul 11, 2022 at 06:35 PM in the 'ACQUISITION' category. From Mon, Jun 27, 2022, the stock recorded 44.44% Up Days and 30.00% Green Days
About La Jolla Pharmaceutical Company (LJPC:NASDAQ)
La Jolla Pharmaceutical Co is an American biopharmaceutical company. It is focused on the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases.
Top 10 Gainers:
- Kaspien Holdings Inc. (KSPN:NASDAQ), 161.92%
- Pliant Therapeutics Inc. (PLRX:NASDAQ), 159.01%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 81.12%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Iterum Therapeutics plc (ITRM:NASDAQ), 40.42%
- Volcon Inc. (VLCN:NASDAQ), 40%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 34.38%
- SQL Technologies Corp. (SKYX:NASDAQ), 32.56%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 27.23%
- Kalera Public Limited Company (KAL:NASDAQ), 20.35%